Penny Clark

Switching from Insulin to Oral Sulfonylureas in Patients with Diabetes Due to Kir6.2 Mutations

Ewan R. Pearson, Isabelle Flechtner, Pål R. Njølstad et al. · New England Journal of Medicine · 2006 · 979 citations · Full text

Genetic cause of hyperglycaemia and response to treatment in diabetes

Ewan R. Pearson, B J Starkey, Roy Powell et al. · The Lancet · 2003 · 599 citations

Metabolic Syndrome, Diabetes Management, Genetic Determinant +10

Cortisol Metabolism in Human Obesity: Impaired Cortisone→Cortisol Conversion in Subjects with Central Adiposity¹

Paul M. Stewart, Abigail Boulton, Sudhesh Kumar et al. · The Journal of Clinical Endocrinology & Metabolism · 1999 · 398 citations · Full text

Resistin and Type 2 Diabetes: Regulation of Resistin Expression by Insulin and Rosiglitazone and the Effects of Recombinant Resistin on Lipid and Glucose Metabolism in Human Differentiated Adipocytes

Philip G. McTernan, Ffolliott M. Fisher, George Valsamakis et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 280 citations

Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes

Wendy M. Macfarlane, Timothy M. Frayling, Sian Ellard et al. · Journal of Clinical Investigation · 1999 · 253 citations · Full text